Advil Congestion effort ties traffic gridlock to cold and flu misery

Share this article:
Advil Congestion effort ties traffic gridlock to cold and flu misery
Advil Congestion effort ties traffic gridlock to cold and flu misery
Don't tell the New York Post, but Pfizer is boosting bike lanes as part of an Advil promotion.

Pfizer Consumer Healthcare donated special snow removal equipment for bike lanes to Chicago, which ranks Number One in the country for traffic congestion, to promote Advil Congestion Relief. Chicago Bears legend and Pro Football Hall of Famer Richard Dent presided over the giveaway of the equipment and 100 new bikes last week. The company is running ads for the brand under the tagline “The Right Relief for the Real Problem, and will be holding similar events in communities around the country as part of its Advil Congestion Relief Project this winter. Visitors to the campaign website, CongestionReliefProject.com, can share their community's congestion relief needs for a chance to win $30,000 towards local congestion relief efforts.

“We are passionate about finding the right relief for the real problem for consumers wherever they need it, from their noses to their communities,” said Kristin Shea, franchise head for upper respiratory and allergy at Pfizer Consumer Healthcare. “We're excited to be hitting the road with the Advil Congestion Relief Project this cold and flu season and look forward to seeing the stories our consumers will share with us about their communities.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...